. Author manuscript; available in PMC: 2015 Mar 26.

Published in final edited form as: Nat Genet. 2013 Oct;45(10):1127–1133. doi: 10.1038/ng.2762

Table 1.

TCGA pan-cancer data set

Tumor type	TCGA ID	Number of cases	Subtypes
Bladder urothelial carcinoma	BLCA	97
Breast invasive carcinoma⁴	BRCA	488	Basal-like, Her2 enriched, luminal B, luminal A
Colon and rectum adenocarcinoma¹¹	COADREAD^a	491	Microsatellite stable (MSS), microsatellite instability (MSI), ultramutators (ultra)
Glioblastoma multiformae⁹	GBM	218
Head and neck squamous cell carcinoma	HNSC	302
Kidney renal clear-cell carcinoma	KIRC	420
Acute myeloid leukemia¹³	LAML	184
Lung adenocarcinoma	LUAD	229
Lung squamous cell carcinoma¹²	LUSC	182
Ovarian serous cystadenocarcinoma¹⁰	OV	446
Uterine corpus endometrioid carcinoma⁵	UCEC	242	Serous-like, endometrioid (low CNA), MSI, ultramutators (ultra)

Colon and rectum tumors were treated as a single sample set by the TCGA.